Suraksha Diagnostic
Suraksha Diagnostic (SURAKSHA) share price was ₹311.70 at the 28 Oct 2026 close; market capitalisation ₹1,623 Cr; P/E (TTM) 45.31; sector Healthcare Services. The share price fell 3.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue rose 20.8% year on year to ₹87.7 Cr and net profit was ₹13 Cr, against ₹9 Cr a year earlier (compared with Jun 2025). Promoters held 49.10% of Suraksha Diagnostic in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 52/100 (Average) as of 28 Oct 2026.
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures as of 28 Oct 2026, 15:31 IST · EPS basis: Consolidated · TTM
Peer Comparison
Healthcare › Healthcare Services › Healthcare Service Provider
| ₹1,922.30 | 59.44 | 32,266 Cr | 12.86 | 0.26% | 20.06% | 25.67% | 2,996 Cr | 545 Cr | |
| ₹1,442.80 | 79.14 | 14,861 Cr | 15.53 | 0.14% | 18.07% | 19.22% | 879 Cr | 187 Cr | |
| ₹551.20 | 56.65 | 11,431 Cr | 7.61 | 0.91% | 12.54% | 15.73% | 1,733 Cr | 203 Cr | |
| ₹494.50 | 44.63 | 7,871 Cr | 15.35 | 2.84% | 27.79% | 33.84% | 894 Cr | 176 Cr | |
| ₹628.40 | 149.98 | 6,319 Cr | 5.66 | 0.00% | 6.88% | 13.46% | 1,079 Cr | 85 Cr | |
| Suraksha Diagnostic (this company) | ₹311.70 | 45.31 | 1,623 Cr | 6.63 | 0.16% | 12.90% | 14.70% | 329 Cr | 35 Cr |
| ₹496.45 | 16.28 | 1,610 Cr | 1.64 | 0.40% | 10.35% | 10.64% | 862 Cr | 98 Cr | |
| Median 7 companies | ₹551.20 | 56.65 | 7,871 Cr | 7.61 | 0.26% | 12.90% | 15.73% | 894 Cr | 176 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
v2.0.0
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has delivered good profit growth of 31.8% CAGR over last 5 years
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bullish
0 of 1 analyst rates Buy, 1 Hold, 0 Sell.
Updated 28 Oct 2026
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 35% · Jun 2026
Analyst Forecasts
Quarterly Results
| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 60 | 52 | 55 | 61 | 67 | 60 | 65 | 73 | 79 | 78 | 81 | 88 |
| Expenses | 39 | 36 | 36 | 40 | 44 | 41 | 46 | 49 | 55 | 55 | 57 | 57 |
| Operating Profit | 21 | 15 | 19 | 21 | 23 | 18 | 19 | 24 | 24 | 23 | 24 | 30 |
| OPM % | 35% | 30% | 35% | 34% | 35% | 31% | 29% | 33% | 31% | 30% | 30% | 35% |
| Other Income | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 |
| Depreciation | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 11 | 11 | 11 |
| PBT | 11 | 6 | 9 | 11 | 14 | 8 | 9 | 12 | 12 | 10 | 10 | 17 |
| Tax % | 24% | 27% | 32% | 27% | 26% | 26% | 22% | 26% | 27% | 28% | 38% | 22% |
| Net Profit | 8 | 5 | 6 | 8 | 10 | 6 | 7 | 9 | 9 | 7 | 6 | 13 |
| EPS (₹) | 1.95 | 1.08 | 1.51 | 1.84 | 2.4 | 1.18 | 1.42 | 1.8 | 1.73 | 1.44 | 1.21 | 2.5 |
Profit & Loss
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 158 | 140 | 223 | 190 | 219 | 252 | 310 | 325 |
| Expenses | 123 | 115 | 174 | 143 | 146 | 170 | 214 | 223 |
| Operating Profit | 34 | 25 | 49 | 47 | 73 | 82 | 96 | 102 |
| OPM % | 22% | 18% | 22% | 25% | 33% | 33% | 31% | 31% |
| Other Income | 2 | -1 | 1 | 1 | 1 | 4 | 3 | 3 |
| Interest | 2 | 2 | 2 | 10 | 10 | 9 | 13 | 14 |
| Depreciation | 13 | 16 | 15 | 32 | 33 | 35 | 41 | 43 |
| PBT | 21 | 6 | 33 | 7 | 31 | 41 | 45 | 49 |
| Tax % | 28% | -1% | 28% | 10% | 26% | 25% | 30% | — |
| Net Profit | 15 | 6 | 24 | 6 | 23 | 31 | 31 | 35 |
| EPS (₹) | 3.53 | 1.49 | 5.51 | 1.51 | 5.48 | 6.11 | 6.18 | 6.88 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 1% | — |
Balance Sheet
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 10 | 10 |
| Reserves | 111 | 118 | 141 | 147 | 171 | 201 | 234 |
| Borrowings | 13 | 18 | 21 | 99 | 92 | 89 | 130 |
| Other Liabilities | 42 | 28 | 32 | 28 | 30 | 33 | 73 |
| Total Liabilities | 173 | 171 | 201 | 281 | 300 | 334 | 448 |
| Fixed Assets | 128 | 119 | 119 | 195 | 212 | 223 | 315 |
| CWIP | 0 | 0 | 1 | 2 | 1 | 11 | 37 |
| Investments | 5 | 5 | 0 | 0 | 0 | 1 | 0 |
| Other Assets | 39 | 46 | 80 | 84 | 87 | 99 | 97 |
| Total Assets | 173 | 171 | 201 | 281 | 300 | 334 | 448 |
Cash Flow
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 31 | 24 | 42 | 44 | 60 | 63 | 82 |
| Investing | -20 | -28 | -44 | -21 | -35 | -40 | -52 |
| Financing | -10 | 3 | 1 | -24 | -25 | -24 | -29 |
| Net Cash Flow | 1 | -1 | 0 | -1 | 0 | 0 | 1 |
| Free Cash Flow | 15 | 8 | 23 | 32 | 18 | 21 | 15 |
| CFO/EBITDA | 111 | 100 | 95 | 109 | 95 | 90 | 99 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 14 | 16 | 12 | 9 | 15 | 20 | 27 |
| Inventory Days | 93 | 62 | 38 | 82 | 89 | 100 | 81 |
| Days Payable | 227 | 177 | 84 | 187 | 193 | 169 | 209 |
| Cash Conversion Cycle | -120 | -99 | -34 | -96 | -89 | -49 | -101 |
| Working Capital Days | -35 | -19 | -15 | -49 | -37 | -23 | -28 |
| ROCE % | — | 8% | 24% | 9% | 17% | 18% | 17% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Suraksha Diagnostic insights
60 extracted metrics + investor summaries across FY20–FY27.
Documents
Frequently Asked Questions about Suraksha Diagnostic
What does Suraksha Diagnostic Ltd do?
Where is Suraksha Diagnostic Ltd (SURAKSHA) listed?
Which sector does Suraksha Diagnostic Ltd belong to?
What is the market capitalisation of Suraksha Diagnostic Ltd?
What is the PE ratio of Suraksha Diagnostic Ltd?
What is the 52-week high and low of Suraksha Diagnostic Ltd?
Does Suraksha Diagnostic Ltd pay dividends?
What is the Return on Equity (ROE) of Suraksha Diagnostic Ltd?
Company Information
Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SURAKSHA.md for Suraksha Diagnostic Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.